elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26752425-3EA06DCD-042F-41F1-9FE8-15FB2B5B40A6
Q26752425-3EA06DCD-042F-41F1-9FE8-15FB2B5B40A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752425-3EA06DCD-042F-41F1-9FE8-15FB2B5B40A6
UK guidelines for the management of bone sarcomas
P2860
Q26752425-3EA06DCD-042F-41F1-9FE8-15FB2B5B40A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752425-3EA06DCD-042F-41F1-9FE8-15FB2B5B40A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ecebb59ce8fd27e8ec7b5e527a588af5021059b
P2860
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.